Navigation Links
Rutgers researchers assess severity of prostate cancers using magnetic resonance imaging
Date:8/10/2010

NEW BRUNSWICK, N.J. Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.

In a presentation next month at the world's premier medical image analysis conference, Rutgers biomedical engineers will report that they achieved over 90% accuracy in distinguishing low-grade from high-grade prostate cancers by running computer analyses of the images and spectra made on 19 patients in an early research study.

"The breakthrough we've had in the last few months is that we see image signatures that distinguish aggressive cancers from less aggressive ones," said Anant Madabhushi, associate professor of biomedical engineering at Rutgers and a member of The Cancer Institute of New Jersey (CINJ).

These studies build on earlier research at Rutgers and elsewhere to identify prostate cancer using powerful, high-resolution magnetic resonance imaging (MRI) technology.

"Now we're getting beyond merely identifying whether a person has cancer or not," he said. "This could lead to better patient management and cost savings."

Biomedical engineering graduate student Pallavi Tiwari will present research results and describe image analysis techniques at the Medical Image Computing and Computer Assisted Intervention (MICCAI) Conference in Bejing, China, on Sept. 22.

Tiwari and Madabhushi worked with John Kurhanewicz, professor of radiology and biomedical imaging at the University of California, San Francisco, to obtain prostate gland images from 19 patients who later had radical prostatectomies. They examined both traditional magnetic resonance (MR) images, which provide two-dimensional pictures of the gland's cellular structure, and MR spectroscopy, which maps concentrations of certain chemicals to locations in the prostate gland. Changes in concentrations of these chemical metabolites choline, creatine and citrate indicate the presence of cancer.

The researchers compared the MR images and spectra to digital images of the actual excised glands, which pathologists identified as having high-grade (aggressive) or low-grade (indolent) tumors using the established Gleason Grading System. They used pattern recognition techniques to recognize characteristics of areas in the MR images and spectra that corresponded to the cancerous tissue in the excised samples. This involved using computerized tools to align the MR views with digitized images of tissue slices, and to match the different resolutions of the images and spectra.

The objective is to "teach" the computer system to accurately and consistently recognize image patterns that correspond to various grades of cancerous tissue without having the tissue samples available to manually verify.

Madabhushi notes that the techniques will have to be evaluated on more people before they can be considered for clinical use. However, he is encouraged by the early results.

Each year, there are more than 27,000 deaths from prostate cancer in the United States and 190,000 new cases diagnosed. Most clinical diagnoses today are based on PSA levels in blood, physical examinations and needle biopsies. While one in six men might expect to get prostate cancer in their lifetimes, only one in 34 will die of it. Recent studies, including one at CINJ, suggest that men with low-risk cancers are receiving aggressive treatment. Improved diagnostic methods such as the Rutgers work could help patients with low-risk cancers and their physicians feel more confident with watchful waiting.


'/>"/>

Contact: Carl Blesch
cblesch@ur.rutgers.edu
732-932-7084 x616
Rutgers University
Source:Eurekalert  

Related biology news :

1. Rutgers researchers discover secrets of nutritious corn breed that withstands rigors of handling
2. Rutgers cell biologist pinpoints how RNA viruses copy themselves
3. NSF grant supports Rutgers-Camden program for science majors
4. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
5. Rutgers to collaborate in $3.4 million effort to improve prostate cancer identification using MRI
6. Rutgers-Camden developing enzyme function database
7. Rutgers research tackles childhood epilepsy
8. Rutgers study finds many consumers ignore food product recalls
9. Evolution and climate change research advances at Rutgers-Camden
10. Rutgers receives US$10 million to establish Institute for Food, Nutrition and Health
11. Rutgers scholar authors definitive biography of reproductive medicine pioneer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rutgers researchers assess severity of prostate cancers using magnetic resonance imaging
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/21/2016)... WAKEFIELD, Massachusetts , March 22, 2016 ... and facial recognition with passcodes for superior security ... MESG ), a leading provider of secure digital communications ... pilot their biometric technology and offer enterprise customers, particularly ... provide secure facial recognition and voice authentication within a ...
(Date:3/14/2016)... MELBOURNE, Florida , March 14, 2016 ... on the growing mobile commerce market, announces the airing of ... York channels starting the week of March 21 st . ... and CNBC, including its popular Squawk on the Street show. ... company focused on the growing mobile commerce market, announces the ...
Breaking Biology News(10 mins):
(Date:5/23/2016)... LONDON , May 23, 2016 ... Boost Efficiency by 40% - Frontage Implement a Single ... Enforce Quality, Compliance and Traceability Within the Bioanalytical lab ... the United States and China ... deployed across its laboratory facilities. In addition to serving as the ...
(Date:5/20/2016)... ... , ... The leading Regenerative Veterinary Medicine Company, VetStem Biopharma ., is ... 100 of their own patients with the VetStem Cell Therapy. Each of these veterinarians ... their patients. , The veterinarians are Dr Ross Rich former owner of Cave ...
(Date:5/19/2016)... ... May 19, 2016 , ... Anton Paar USA, located in ... office building is complete. The new structure adds a third office building to the ... USA purchased 2.4 acres of land, along with office space adjacent to the ...
(Date:5/19/2016)... 19, 2016 Regen ... PINK: RGBPP) announced today initiation of a preclinical ... blood based cancer immunotherapeutic product leveraging its NR2F6 ... described a generation of cord blood derived killer ... silencing.  The product in development will be a ...
Breaking Biology Technology: